Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy in the United States
Caregivers of patients with DMD demonstrated risk tolerance (positive value of hope) for therapies that could delay LoA.
Authors
- Alexa C. Klimchak (ORCID: https://orcid.org/0000-0001-8196-7093)
- Natasha Kulkarni
- Ivana Audhya
- Jason Shafrin (ORCID: https://orcid.org/0000-0001-8444-5979)
- Nadine Zawadzki (ORCID: https://orcid.org/0000-0002-3379-9424)
- Lauren E. Sedita (ORCID: https://orcid.org/0000-0003-0899-1585)
- Moises Marin
Institutions
- Center For Policy Research (US)
- Sarepta Therapeutics (United States) (US)
- Center for the Study of Healthcare Provider Behavior (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/03007995.2025.2550347
- Primary Topic
- Muscle Physiology and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00